TrialThe oncologist2017

A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer.

Xiao X Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.